Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type
Blogs Testimonial
Sectors (2)
Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals
Expertises
Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants
Food and Feed Remove filter Pharmaceuticals Remove filter Clear all

27 results

Newest first
Newest first Oldest first A–Z Z–A
Pharmaceuticals Litigation Regulatory Compliance and Enforcement Testimonial

We have litigated in a pharmaceutical case concerning the validity of marketing authorisations.

Pharmaceuticals Regulatory Compliance and Enforcement Testimonial

We regularly assist clients with pricing and reimbursement procedures in the Netherlands.

Pharmaceuticals Commercial Contracts Testimonial

We have negotiated clinical trial agreements on behalf of several sponsors.

Pharmaceuticals Regulatory Compliance and Enforcement Testimonial

We have advised pharmaceutical companies with legal advice across the full product lifecycle, from early-stage development through to market authorisation and post-marketing compliance.

Diagnostics Pharmaceuticals Regulatory Compliance and Enforcement Testimonial

We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.

Healthcare Pharmaceuticals Regulatory Compliance and Enforcement Testimonial

We have advised pharmacies on the regulatory aspects of pharmaceutical compounding.

Biotech Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.